<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drugDebug/PMC7002824/results/search/disease/results.xml">
  <result pre="open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). Abstract" exact="Viral" post="infections are responsible for many illnesses, and recent outbreaks"/>
  <result pre="access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). Abstract Viral" exact="infections" post="are responsible for many illnesses, and recent outbreaks have"/>
  <result pre="drugs, they are often unsuccessful due to the generation of" exact="viral" post="mutants and less effective against their target virus. Identifying"/>
  <result pre="toxicity. There are numerous evidences showing its inhibitory role against" exact="infection" post="of various viruses such as HIV, Influenza, Enterovirus 71"/>
  <result pre="(CVA16). The mechanisms involve either inhibition of proteins essential for" exact="viral" post="entry, replication and infection or regulation of cellular pathways"/>
  <result pre="either inhibition of proteins essential for viral entry, replication and" exact="infection" post="or regulation of cellular pathways such as Akt-Mtor (mammalian"/>
  <result pre="effect and their possible molecular mechanisms against Influenza virus, HIV," exact="Hepatitis" post="virus, Dengue virus and Chikungunya virus. Microbiology; Pharmaceutical science;"/>
  <result pre="their possible molecular mechanisms against Influenza virus, HIV, Hepatitis virus," exact="Dengue" post="virus and Chikungunya virus. Microbiology; Pharmaceutical science; Health sciences;"/>
  <result pre="Microbiology; Pharmaceutical science; Health sciences; Public health; Pharmacology; Coumarin; Antiviral;" exact="Viral" post="replication; Natural product; Inhibitor; Mechanism. Keywords Microbiology Pharmaceutical science"/>
  <result pre="Microbiology Pharmaceutical science Health sciences Public health Pharmacology Coumarin Antiviral" exact="Viral" post="replication Natural product Inhibitor Mechanism 1 Introduction Viruses pose"/>
  <result pre="outbreaks, epidemics and pandemics worldwide (Table 1), like Swine Influenza," exact="Avian" post="Influenza, Dengue fever. Even though various types of treatment"/>
  <result pre="and pandemics worldwide (Table 1), like Swine Influenza, Avian Influenza," exact="Dengue" post="fever. Even though various types of treatment methods are"/>
  <result pre="though various types of treatment methods are available to cure" exact="viral" post="diseases, like chemotherapy [1, 2, 3, 4] but owing"/>
  <result pre="[8, 9, 10]. Table 1 Overview of outbreaks of some" exact="viral" post="diseases across the world. Table 1 Viral diseases Period"/>
  <result pre="outbreaks of some viral diseases across the world. Table 1" exact="Viral" post="diseases Period of occurrence Estimated number of deaths References"/>
  <result pre="50-100 million [79] H1N1 Swine Influenza (2009) 284,500 [80] H5N1" exact="Avian" post="(bird) Influenza- (2003–2019) 455 [81] Seasonal Influenza (Annually) 0.29–0.65"/>
  <result pre="Influenza- (2003–2019) 455 [81] Seasonal Influenza (Annually) 0.29–0.65 million [82]" exact="Viral" post="Hepatitis B &amp;amp;C Annually 1.4 million [83] HIV 1981–2018"/>
  <result pre="(2003–2019) 455 [81] Seasonal Influenza (Annually) 0.29–0.65 million [82] Viral" exact="Hepatitis" post="B &amp;amp;C Annually 1.4 million [83] HIV 1981–2018 32"/>
  <result pre="&amp;amp;C Annually 1.4 million [83] HIV 1981–2018 32 million [84]" exact="Dengue" post="Annually 25,000 [85] Various natural compounds including herbal products"/>
  <result pre="HIV, Enterovirus 71 (EV71), coxsackievirus A16 (CVA16), dengue virus and" exact="chikungunya" post="virus [15, 16, 17, 18]. This review will elucidate"/>
  <result pre="inhibitory effects and will also illustrate its potential relevance in" exact="viral" post="diseases and antiviral therapies (See Figure 1, Figure 2)."/>
  <result pre="Figure 1 Antiviral Mechanism of coumarin in Infected Host cells:" exact="Viral infection" post="involves various stages (1) binding of virion with receptor"/>
  <result pre="1 Antiviral Mechanism of coumarin in Infected Host cells: Viral" exact="infection" post="involves various stages (1) binding of virion with receptor"/>
  <result pre="the cell surface, followed by (2) fusion and entry, (3)" exact="viral" post="genome replication and transcription, (4) translation and (5) virion"/>
  <result pre="ultimately budding and release. Chemotherapeutics target these critical stages of" exact="viral" post="life cycle. Likewise, coumarin inhibits many of the proteins"/>
  <result pre="Coumarin is a therapeutic agent, found as a naturally occurring" exact="secondary" post="metabolite in plants, bacteria, fungi, essential oils and can"/>
  <result pre="of coumarins make them a potential drug candidate against many" exact="viral" post="and bacterial diseases. Many of natural, synthetic, conjugated, hybrid"/>
  <result pre="make them a potential drug candidate against many viral and" exact="bacterial diseases." post="Many of natural, synthetic, conjugated, hybrid potential candidate lead"/>
  <result pre="scientists to study its significance in the prevention of other" exact="viral" post="diseases. 3 Coumarin as anti-viral agent 3.1 Anti-hepatitis virus"/>
  <result pre="anti-viral agent 3.1 Anti-hepatitis virus The available therapeutic treatment for" exact="infection" post="caused by the hepatitis C virus have many adverse"/>
  <result pre="virus The available therapeutic treatment for infection caused by the" exact="hepatitis" post="C virus have many adverse effects (Headache, fatigue, nausea,"/>
  <result pre="associated with anti-HCV drugs [33]. Hepatocarcinoma (HCC) is associated with" exact="chronic hepatitis" post="C virus (HCV) infection which involves increase in plasma"/>
  <result pre="with anti-HCV drugs [33]. Hepatocarcinoma (HCC) is associated with chronic" exact="hepatitis" post="C virus (HCV) infection which involves increase in plasma"/>
  <result pre="Hepatocarcinoma (HCC) is associated with chronic hepatitis C virus (HCV)" exact="infection" post="which involves increase in plasma alanine transferase (ALT) levels"/>
  <result pre="the liver to a hypocarcinogenic state which was detected by" exact="lower" post="levels of plasma ALT by using mouse liver injury"/>
  <result pre="polymerase components of virus to inhibit its replication, NS5B, a" exact="hepatitis" post="C virus polymerase is a novel target for newly"/>
  <result pre="binding in thumb pocket-1 (TP-1) of NS5B and inhibit the" exact="viral" post="polymerase activity [41]. The first study, in which coumarins"/>
  <result pre="restrict to HCV, many studies have shown its activity against" exact="Hepatitis" post="B virus (HBV) also. Natural pyranocoumarins nordentatin and clausarin"/>
  <result pre="plant Clausena excavate [43]. These compounds were found to inhibit" exact="hepatitis" post="B virus surface antigen (HBsAg) in HepA2 cells. Their"/>
  <result pre="[44]. From the aforementioned studies, we can deduce that in" exact="hepatitis" post="virus infection, coumarin has shown to target a wide"/>
  <result pre="From the aforementioned studies, we can deduce that in hepatitis" exact="virus infection," post="coumarin has shown to target a wide range of"/>
  <result pre="the cell, proteins that are related to polymerase responsible for" exact="viral" post="replication &amp;amp; factors involved in interferon signaling pathways. 3.2"/>
  <result pre="4-Phenylcoumarins, Hybrid coumarin analogue, Toddacoumaquinone have shown pharmacological effect against" exact="HIV infection." post="They inhibit HIV protease, integrase, reverse transcriptase, viral DNA"/>
  <result pre="against HIV infection. They inhibit HIV protease, integrase, reverse transcriptase," exact="viral" post="DNA replication, vpr, sp1-related genes (cell cycle arrest), Tat,"/>
  <result pre="HIV-protease and Reverse transcriptase [52]. Membrane fusion by binding of" exact="viral" post="envelop protein and CD4 of T cells/Macrophages is the"/>
  <result pre="and CD4 of T cells/Macrophages is the crucial step in" exact="HIV infection" post="[53]. Tricyclic coumarin GUT70, a natural compound isolated from"/>
  <result pre="CD4 of T cells/Macrophages is the crucial step in HIV" exact="infection" post="[53]. Tricyclic coumarin GUT70, a natural compound isolated from"/>
  <result pre="has the ability to reduce the membrane fluidity that affects" exact="viral" post="entry. Matsuda et al., found that GUT-70 reduced membrane"/>
  <result pre="GUT-70 reduced membrane fluidity, inhibited membrane fusion and thus inhibited" exact="HIV infection" post="[53]. Further, expression of the HIV-1 receptor (CD4) and"/>
  <result pre="reduced membrane fluidity, inhibited membrane fusion and thus inhibited HIV" exact="infection" post="[53]. Further, expression of the HIV-1 receptor (CD4) and"/>
  <result pre="it cannot be fully effective until the problem of latent" exact="viral" post="reservoir is resolved. To solve this problem Coumarin derivatives,"/>
  <result pre="delay in vaccine production because of the evolution of drug-resistant" exact="viral" post="mutants attributed to the mutation or reassortment potential of"/>
  <result pre="an influenza structural protein that is a constituent of vRNPs" exact="viral" post="ribonucleoprotein complex important for viral replication [61]. RNA sequencing"/>
  <result pre="is a constituent of vRNPs viral ribonucleoprotein complex important for" exact="viral" post="replication [61]. RNA sequencing technology has confirmed that the"/>
  <result pre="cytokine-cytokine receptor interactions. Recently, the mechanism of action against influenza" exact="viral infection" post="of eleutheroside B1 has been assessed showing that the"/>
  <result pre="receptor interactions. Recently, the mechanism of action against influenza viral" exact="infection" post="of eleutheroside B1 has been assessed showing that the"/>
  <result pre="is POLR2A gene which is responsible for the expression of" exact="viral" post="polymerase [62]. Thiazolyl-coumarin hybrids synthesized by Osman et al.,"/>
  <result pre="shown this anti-influenza activity is probably because of inhibition of" exact="viral" post="envelope protein neuraminidase [63]. Similarly, derivatives of coumarin, bis(triazolothiadiazinyl"/>
  <result pre="compound containing both coumarin and monoterpenoid derivative in influenza was" exact="viral" post="hemagglutinin HA which is involved in viral entry in"/>
  <result pre="in influenza was viral hemagglutinin HA which is involved in" exact="viral" post="entry in host cell by membrane fusion. The activities"/>
  <result pre="activity of the virus by blocking the early stages of" exact="viral" post="reproduction [60]. Due to the high mutation tendency of"/>
  <result pre="reproduction [60]. Due to the high mutation tendency of influenza" exact="viral" post="proteins [66], redox-sensitive pathways which are useful for viral"/>
  <result pre="influenza viral proteins [66], redox-sensitive pathways which are useful for" exact="viral" post="replication and are independent of variability of the strains,"/>
  <result pre="strains, are gaining importance as the new target to inhibit" exact="viral infection." post="Coumarins oxidized with 2-iodobenzoic acid (IBX) with different catechol"/>
  <result pre="Anti-dengue virus Coumarin has the potential to significantly suppress the" exact="Dengue" post="and chikungunya viral infections in vitro. However, the need"/>
  <result pre="Coumarin has the potential to significantly suppress the Dengue and" exact="chikungunya" post="viral infections in vitro. However, the need is to"/>
  <result pre="has the potential to significantly suppress the Dengue and chikungunya" exact="viral" post="infections in vitro. However, the need is to investigate"/>
  <result pre="the potential to significantly suppress the Dengue and chikungunya viral" exact="infections" post="in vitro. However, the need is to investigate the"/>
  <result pre="and other effects on in vivo model [68]. Flaviviruses like" exact="Dengue" post="virus need their polyprotein processing by viral NS3 protease"/>
  <result pre="[68]. Flaviviruses like Dengue virus need their polyprotein processing by" exact="viral" post="NS3 protease called NS3pro for its replication activities. Activation"/>
  <result pre="derivatives have significant binding affinity with the binding site of" exact="viral" post="protease complex suggesting its inhibitory role [70]. In a"/>
  <result pre="haplopin) were extracted and their inhibitory activities were checked against" exact="Dengue" post="infection. They exhibited weak anti-dengue activity when used separately,"/>
  <result pre="Resvertrol (RESV), a phytoalexin (hydroxylated derivative of coumarin) against dengue" exact="viral infection" post="were investigated. In case of Dengue infection, a DNA"/>
  <result pre="(RESV), a phytoalexin (hydroxylated derivative of coumarin) against dengue viral" exact="infection" post="were investigated. In case of Dengue infection, a DNA"/>
  <result pre="coumarin) against dengue viral infection were investigated. In case of" exact="Dengue" post="infection, a DNA binding protein namely, high mobility group"/>
  <result pre="conjugates have been used to see their inhibitory role against" exact="chikungunya" post="viruses. Jih Ru Hwu et al., used the triply"/>
  <result pre="the triply conjugated uracil-coumarin-arenes compound to see structure-activity relationship against" exact="chikungunya" post="virus. In this research, coumarin central moiety was found"/>
  <result pre="size of conjugated moiety (benzouracil &amp;gt; thymine &amp;gt; uracil) and" exact="chikungunya" post="inhibitory action [3]. Same research group have synthesized thioguanosine-coumarin"/>
  <result pre="target molecule [74]. Similar reports were found in the viremia" exact="infection" post="caused by spring viremia of carp virus (SVCV), a"/>
  <result pre="The anti-viral activity was displayed in the form of reduced" exact="horizontal" post="transmission of SVCV, thus decreasing the mortality and viral"/>
  <result pre="reduced horizontal transmission of SVCV, thus decreasing the mortality and" exact="viral" post="titer in the fish body [76]. 7-[6-(2-methylimidazole) hexyloxy] coumarin,"/>
  <result pre="likely mechanism of action that will refine our knowledge of" exact="viral" post="treatment. As summarized here, coumarin (and its derivatives) can"/>
  <result pre="can target various enzymes and pathways that are essential for" exact="viral" post="entry, survival and infection. These studies have given many"/>
  <result pre="3RuJ.KapoorM.TsayS.LinC.ChuK.Benzouracil – coumarin – arene conjugates as inhibiting agents for" exact="chikungunya" post="virusAntivir. Res.201516 4BandarageU.K.ClarkM.P.PerolaE.GaoH.JacobsM.D.TsaiA.Novel 2-substituted 7-azaindole and 7-azaindazole analogues as"/>
  <result pre="approaches and clinical perspectives of anthocyanins in the management of" exact="viral" post="diseasesFront. Pharmacol.10201912330728774 11MycolV.KotwalG.J.LongumP.Natural Antivirals against Human Viruses Bitter melonVirol."/>
  <result pre="structure-activity relationshipsMol. Nutr. Food Res.2018174 26LailaU.AkramM.AliM.MehmmodA.NaheedH.ImtiazA.TahirM.OwaisA.NaveedG.MuhammadM.NaheedR.ShaheenG.UllahQ.ZahidR.Role of medicinal plants in" exact="HIV/AIDS" post="therapyClin. Exp. Pharmacol. Physiol.2019111 27SrikrishnaD.A review on pharmacological properties"/>
  <result pre="acutely and chronically infected cellsBioorg. Med. Chem. Lett23201360660923290051 29SandmannL.SchulteB.MannsM.P.MaasoumyB.Treatment of" exact="chronic hepatitis" post="C: efficacy, side effects and complicationsVis. Med.352019161170 30MannsM.P.WedemeyerH.CornbergM.Treating viral"/>
  <result pre="and chronically infected cellsBioorg. Med. Chem. Lett23201360660923290051 29SandmannL.SchulteB.MannsM.P.MaasoumyB.Treatment of chronic" exact="hepatitis" post="C: efficacy, side effects and complicationsVis. Med.352019161170 30MannsM.P.WedemeyerH.CornbergM.Treating viral"/>
  <result pre="chronic hepatitis C: efficacy, side effects and complicationsVis. Med.352019161170 30MannsM.P.WedemeyerH.CornbergM.Treating" exact="viral hepatitis" post="C: efficacy, side effects, and complicationsGut5520061350135916905701 31LyT.PermanenteK.CaliforniaN.DermatolA.A.TineaM.S.GesD.D.ManagementG.R.CosmetC.DermatolI.ScH.TineaB.J.JsM.InfectE.LmD.BgR.KhR.ControlI.EpidemiolH.PcS.RcS.JournalB.Cutaneous side-effects of"/>
  <result pre="hepatitis C: efficacy, side effects and complicationsVis. Med.352019161170 30MannsM.P.WedemeyerH.CornbergM.Treating viral" exact="hepatitis" post="C: efficacy, side effects, and complicationsGut5520061350135916905701 31LyT.PermanenteK.CaliforniaN.DermatolA.A.TineaM.S.GesD.D.ManagementG.R.CosmetC.DermatolI.ScH.TineaB.J.JsM.InfectE.LmD.BgR.KhR.ControlI.EpidemiolH.PcS.RcS.JournalB.Cutaneous side-effects of"/>
  <result pre="U. K. experienceBr. J. Dermatol.201420142015 32HenryB.Drug pricing &amp;amp; challenges to" exact="hepatitis" post="C treatment accessJ. Heal. Biomed. Law.142018265283http://www.ncbi.nlm.nih.gov/pubmed/30258323%0Ahttp://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC6152913 33TsayS.LinS.HuangW.HsuM.HwangK.C.LinC.HorngJ.ChenI.HwuJ.R.ShiehF.LeyssenP.NeytsJ.Synthesis and Structure-activity"/>
  <result pre="Biomed. Law.142018265283http://www.ncbi.nlm.nih.gov/pubmed/30258323%0Ahttp://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC6152913 33TsayS.LinS.HuangW.HsuM.HwangK.C.LinC.HorngJ.ChenI.HwuJ.R.ShiehF.LeyssenP.NeytsJ.Synthesis and Structure-activity relationships of imidazole-coumarin conjugates against" exact="hepatitis" post="C virusMolecules2016 34RinoY.OhkawaS.ShimizuA.TamaiS.MiyakawaK.AokiH.ImadaT.ShindoK.OkamotoN.TotsukaS.Association between high serum alanine aminotransferase levels"/>
  <result pre="and more rapid development and higher rate of incidence of" exact="hepatocellular carcinoma" post="in patients with hepatitis C virus-associated cirrhosisCancer199958959510440686 35O. PaperClose"/>
  <result pre="more rapid development and higher rate of incidence of hepatocellular" exact="carcinoma" post="in patients with hepatitis C virus-associated cirrhosisCancer199958959510440686 35O. PaperClose"/>
  <result pre="higher rate of incidence of hepatocellular carcinoma in patients with" exact="hepatitis" post="C virus-associated cirrhosisCancer199958959510440686 35O. PaperClose association between high serum"/>
  <result pre="association between high serum ALT and more rapid recurrence of" exact="hepatocellular carcinoma" post="in hepatectomized patients with HCV-associated liver cirrhosis and hepatocellular"/>
  <result pre="between high serum ALT and more rapid recurrence of hepatocellular" exact="carcinoma" post="in hepatectomized patients with HCV-associated liver cirrhosis and hepatocellular"/>
  <result pre="rapid recurrence of hepatocellular carcinoma in hepatectomized patients with HCV-associated" exact="liver cirrhosis" post="and hepatocellular carcinomaIntervirology20002026081510773734 36OkamotoT.KajinoK.HinoO.Hepatoprotective drugs for the treatment of"/>
  <result pre="recurrence of hepatocellular carcinoma in hepatectomized patients with HCV-associated liver" exact="cirrhosis" post="and hepatocellular carcinomaIntervirology20002026081510773734 36OkamotoT.KajinoK.HinoO.Hepatoprotective drugs for the treatment of"/>
  <result pre="and hepatocellular carcinomaIntervirology20002026081510773734 36OkamotoT.KajinoK.HinoO.Hepatoprotective drugs for the treatment of virus-induced" exact="chronic" post="hepatitis;: from hypercarcinogenic state to hypocarcinogenic stateREVIEW — Current"/>
  <result pre="38HsuM.ShiehF.LinC.HwangK.C.Coumarins hinged directly on benzimidazoles and their ribofuranosides to inhibit" exact="hepatitis" post="C virusSCEur. J. Med. Chem.2013 39NeytsJ.De ClercqE.SinghaR.ChangY.H.DasA.R.ChakrabortyS.K.Structure - activity"/>
  <result pre="40HwuJ.R.LinS.TsayS.De ClercqE.LeyssenP.NeytsJ.Coumarin - purine ribofuranoside conjugates as new agents against" exact="hepatitis" post="C virusJ. Med. Chem.20112114212621375337 41NicholsD.B.LeR.A.C.BasuA.ChudayeuM.De FP.MoraesD.TaleleT.T.PauloR.R.Kaushik-basuN.Evaluation of coumarin and"/>
  <result pre="inhibitorsChem. Biol. Drug Des.815201360761423311976 42PengH.ChenW.LeeJ.YangS.TzengC.LinY.YangS.Novel anilinocoumarin derivatives as agents against" exact="hepatitis" post="C virus by the induction of IFN-mediated antiviral responsesOrg."/>
  <result pre="fluidityBiochem. Biophys. Res. Commun.457201528829425576356 55HaradaS.YusaK.MondeK.AkaikeT.MaedaY.Influence of membrane fluidity on human" exact="immunodeficiency" post="virus type 1 entryBiochem. Biophys. Res. Commun.329200548048615737612 56OlmedoD.A.LuisL.OlmoE.BedoyaL.M.MuñozE.FelicianoA.S.GuptaM.P.Neoflavonoids as"/>
  <result pre="Res. Commun.457201528829425576356 55HaradaS.YusaK.MondeK.AkaikeT.MaedaY.Influence of membrane fluidity on human immunodeficiency virus" exact="type 1" post="entryBiochem. Biophys. Res. Commun.329200548048615737612 56OlmedoD.A.LuisL.OlmoE.BedoyaL.M.MuñozE.FelicianoA.S.GuptaM.P.Neoflavonoids as inhibitors of HIV-1"/>
  <result pre="anti-influenza activity of monoterpene-containing substituted coumarinsBioorg. Med. Chem. Lett2720172920292528501512 61WangY.YanW.ChenQ.HuangW.YangZ.LiX.WangX.Inhibition" exact="viral" post="RNP and anti-in fl ammatory activity of coumarins against"/>
  <result pre="from the seeds of Mammea americana and Tabernaemontana cymosa on" exact="Dengue" post="and Chikungunya virus infectionsBMC Complement Altern. Med.201711228049463 69ErbelP.SchieringN.ArcyA.D.RenatusM.KroemerM.LimS.P.YinZ.KellerT.H.VasudevanS.G.HommelU.Structural basis"/>
  <result pre="reveals a novel role for HMGB1 in regulation of the" exact="type 1" post="interferon response in dengue virus infectionNat. Publ. Gr.2017112 73RuJ.HuangW.LinS.TanK.European"/>
  <result pre="coumarin-based antihistamine as an anti-filoviral entry inhibitorAntivir. Res.2017 75ShenY.LiuL.FengC.HuY.ChenC.WangG.ZhuB.Fish and" exact="Shell" post="fi sh Immunology Synthesis and antiviral activity of a"/>
  <result pre="derivative enhances the antiviral response to spring viremia of carp" exact="virus infection" post="in zebrafish Authors: SCVirus Res.2019 79MorensD.M.TaubenbergerJ.K.HarveyH.A.MemoliM.J.The 1918 influenza pandemic:"/>
  <result pre="enhances the antiviral response to spring viremia of carp virus" exact="infection" post="in zebrafish Authors: SCVirus Res.2019 79MorensD.M.TaubenbergerJ.K.HarveyH.A.MemoliM.J.The 1918 influenza pandemic:"/>
  <result pre="Dis.129201268769522738893 81World Health OrganizationCumulative Number of Confirmed Human Cases for" exact="Avian" post="Influenza A (H5N1) Reported to WHO, 2003-20192019World Health OrganizationGeneva,"/>
  <result pre="Switzerland 82World Health OrganizationUp to 650 000 people die of" exact="respiratory" post="diseases linked to seasonal flu each year2017WHO News release"/>
  <result pre="to seasonal flu each year2017WHO News release 83collab: WHO, WGlobal" exact="Hepatitis" post="Report 20172017World Health OrganizationGeneva 84Global, H. I. V. AIDS"/>
  <result pre="V. AIDS Statistics–2018 Fact Sheet2019UNAIDS 85World Health OrganizationGlobal Strategy for" exact="Dengue" post="Prevention and Control: 2012–20202018Avilable from:http://www.who.int/denguecontrol/9789241504034/en/Accessed, 18"/>
 </snippets>
</snippetsTree>
